EBRT stands for external beam radiation therapy, the most common form of radiation treatment for cancer. A machine called a linear accelerator directs high-energy beams at a tumor from outside your body, damaging the DNA inside cancer cells so they can no longer grow or divide. It’s a local treatment, meaning it targets a specific area rather than affecting your whole body the way chemotherapy does. Most people receive EBRT as a series of short daily sessions over several weeks, though newer approaches can condense treatment into far fewer visits.
How EBRT Works
The linear accelerator generates beams of photons (high-energy X-rays) or, in some specialized centers, protons. These beams pass through the skin and underlying tissue to reach the tumor. Photon beams scatter small amounts of radiation along their path through the body, which is why treatment planning focuses so heavily on minimizing exposure to surrounding healthy tissue. Proton beams behave differently: they deposit most of their energy at a specific depth and then stop, rather than continuing through the body. This makes proton therapy especially useful for tumors near sensitive structures, like brain tumors in children or cancers close to the spinal cord.
Types of EBRT
Several techniques fall under the EBRT umbrella, each refining how precisely the radiation reaches the tumor.
- 3D conformal radiation therapy (3D-CRT) shapes the beams to match the tumor’s outline using imaging scans taken during planning.
- Intensity-modulated radiation therapy (IMRT) goes a step further by varying the strength of the beam across the treatment field, allowing higher doses to hit the tumor while nearby organs receive less.
- Volumetric modulated arc therapy (VMAT) delivers radiation as the machine rotates around you in an arc. Compared to IMRT, VMAT typically reduces treatment time by up to 70% and delivers lower doses to surrounding organs.
- Stereotactic body radiation therapy (SBRT) uses extremely precise, high-dose beams delivered in just one to five sessions rather than weeks of daily visits. Each session delivers a much larger dose than conventional treatment.
- Image-guided radiation therapy (IGRT) incorporates imaging right on the treatment machine, so the care team can verify the tumor’s exact position before each session and adjust if it has shifted even slightly.
Your radiation oncologist selects the technique based on tumor location, size, and how close it sits to organs that need protection.
What Happens Before Treatment Starts
EBRT requires careful preparation before the first dose is ever delivered. The process follows a specific sequence: simulation, contouring, treatment planning, quality checks, and finally the first treatment session.
Simulation is essentially a rehearsal. You lie on a table in the exact position you’ll be in during treatment while a CT scan maps the tumor and surrounding anatomy. The team may create a custom mold or mesh mask to keep you perfectly still. Small permanent tattoos (tiny ink dots about 2 to 3 millimeters across) are often placed on your skin to mark alignment points. These ensure you’re positioned identically at every session. Some centers now use surface-guided imaging systems that can align you without tattoos, though ink marking remains the most widely used method worldwide.
After simulation, your radiation oncologist outlines the tumor and nearby organs on the scan images. A medical physicist then builds a treatment plan that calculates beam angles, intensities, and doses to maximize radiation to the cancer while keeping exposure to healthy tissue as low as possible. The plan goes through quality assurance checks before treatment begins.
What a Treatment Session Feels Like
Each session is painless. You won’t feel the radiation beam at all. Most of your time in the treatment room is spent on positioning: lying still on the table while therapists align you using skin marks or imaging. The actual beam delivery typically lasts only a few minutes, though the entire appointment usually takes 15 to 30 minutes including setup.
A conventional course of EBRT often runs five days a week for several weeks. A common schedule for lung cancer, for example, is 30 sessions over six weeks. Breast cancer treatment traditionally followed a similar timeline, but moderately hypofractionated schedules (15 sessions over three weeks) are now standard for most patients. An even shorter option, ultrahypofractionation, condenses treatment to just five sessions over one week. Ten-year follow-up data from the FAST-Forward trial, presented at the 2025 ESTRO conference, confirmed that this five-session approach is as effective as the three-week schedule for eligible breast cancer patients, with similar long-term side effects and lower acute skin irritation.
Side Effects: Short-Term and Long-Term
Because EBRT damages rapidly dividing cells, both cancerous and healthy, side effects depend heavily on which part of the body is being treated. They generally fall into two categories based on timing.
Acute side effects appear within the first two to three weeks of treatment. Skin in the treated area may become red, dry, or tender, similar to a sunburn. If you’re receiving radiation to the abdomen or pelvis, nausea, cramping, and diarrhea are common. Fatigue is nearly universal, often building gradually over the course of treatment. These effects usually resolve within a few weeks after your final session.
Late side effects can emerge months or even years later. They tend to involve tissues that don’t regenerate as quickly: scarring (fibrosis) in the treated area, small visible blood vessels on the skin, changes in taste if the head or neck was treated, or stiffness in jaw muscles. The risk and severity of late effects depend on the total radiation dose and how much healthy tissue was exposed, which is why treatment planning prioritizes precision.
How Precision Keeps Improving
Modern EBRT machines include built-in safety features that would have been impossible a generation ago. Multileaf collimators, essentially dozens of thin metal leaves inside the machine’s head, can reshape the beam in real time to match the tumor’s contour from every angle. Onboard imaging systems let the team take X-rays or even MRI scans while you’re on the table, catching any shift in tumor position before the beam fires.
Some newer systems combine an MRI scanner with a linear accelerator, allowing clinicians to watch the tumor in real time during treatment. For lung tumors that move with each breath, this means the beam can pause when the tumor drifts out of range (a technique called beam gating) or the collimator leaves can track the tumor’s motion automatically. Studies have shown that this kind of tracking allows smaller safety margins around the tumor, which translates directly to less radiation hitting healthy lung tissue.
Artificial intelligence is also reshaping the treatment planning process. AI-powered tools can automatically outline tumors and organs on scan images, a task that previously took a physician significant time. Automated planning systems are already being used in some clinics and in global access initiatives like the Radiation Planning Assistant, which aims to bring high-quality treatment plans to centers in lower-resource settings. AI automation is also making same-day treatment feasible, where the time between your planning scan and your first dose shrinks from days to hours.
Who Gets EBRT
EBRT is used across a wide range of cancers, either as the primary treatment, after surgery to destroy remaining cancer cells, or alongside chemotherapy. It’s one of the most common cancer treatments overall. Proton therapy, a specialized form of EBRT, is particularly valuable for pediatric cancers because children’s developing tissues are more vulnerable to radiation scatter, and protons’ ability to stop at the tumor spares growing organs behind it.
Your treatment team considers the cancer type, stage, location, and your overall health when recommending EBRT. In many cases it’s combined with other therapies. For early-stage cancers in certain locations, SBRT can serve as a stand-alone treatment, delivering curative doses in under a week without surgery.